Literature DB >> 6713358

Ph1-positive acute leukemia with a 17q;21q translocation.

P C Nowell, D Wilmoth, J Hoxie, A P Lyss.   

Abstract

Chromosome studies on the neoplastic cells of an adult patient with poorly differentiated acute leukemia revealed two Ph1-positive subpopulations, with and without a 17q;21q (q22;q22) translocation. The breakpoints appeared to be the same as in the 8;21 and 15;17 translocations of acute mytelogenous leukemia (AML) and acute promyelocytic leukemia (APL), emphasizing the significance of rearrangements involving these sites in the pathogenesis of acute leukemia. Terminally, there was clonal evolution, with the new predominant subline having an additional translocation, 1q;19q, resulting in trisomy for most of 1q and, apparently, additional selective advantage.

Entities:  

Mesh:

Year:  1984        PMID: 6713358     DOI: 10.1016/0165-4608(84)90007-4

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13).

Authors:  O W McBride; D Merry; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

2.  The nerve growth factor receptor gene is at human chromosome region 17q12-17q22, distal to the chromosome 17 breakpoint in acute leukemias.

Authors:  K Huebner; M Isobe; M Chao; M Bothwell; A H Ross; J Finan; J A Hoxie; A Sehgal; C R Buck; A Lanahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  The effects of exercise on chemotherapy-induced peripheral neuropathy symptoms in cancer patients: a systematic review and meta-analysis.

Authors:  Wen-Li Lin; Ruey-Hsia Wang; Fan-Hao Chou; I-Jung Feng; Ching-Ju Fang; Hsiu-Hung Wang
Journal:  Support Care Cancer       Date:  2021-03-04       Impact factor: 3.603

4.  A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia.

Authors:  A I Dayton; J R Selden; G Laws; D J Dorney; J Finan; P Tripputi; B S Emanuel; G Rovera; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.